Effects of Nintedanib on Mesenchymal Stem Cells derived from IPF patients
Martina Bonifazi(Marche Polytechnic University), Monia Orciani(Marche Polytechnic University), Mariangela Di Vincenzo(Marche Polytechnic University), Francesca Barbisan(Azienda Ospedaliero-Universitaria delle Marche), Gaia Goteri(Marche Polytechnic University), Pamela Pellegrino(Marche Polytechnic University), Federico Mei(Ospedali Riuniti di Ancona), Majed Refai(Azienda Ospedaliero-Universitaria delle Marche), Francesca Gonnelli(Marche Polytechnic University)
Cited by 0
Related Papers
DNA damage response (DDR) and senescence: shuttled inflamma-miRNAs on the stage of inflamm-aging
|Oncotarget|2015|164
ERS/ESTS statement on the management of pleural infection in adults
|European Respiratory Journal|2022|136
Biofabrication and Bone Tissue Regeneration: Cell Source, Approaches, and Challenges
|Frontiers in Bioengineering and Biotechnology|2017|125
Ciprofloxacin-modified electrosynthesized hydrogel coatings to prevent titanium-implant-associated infections
|Acta Biomaterialia|2010|112
Mesenchymal Stem Cells Neuronal Differentiation Ability: A Real Perspective for Nervous System Repair?
|Current Stem Cell Research & Therapy|2011|108